301160: A pivotal clinical study to investigate the safety and efficacy of efimosfermin alfa injection in participants with biopsyconfirmed F2- or F3-stage MASH (BOS-580-301)

efimosfermin alfa (GSK6519754) - GSK

Jun 11, 2026